Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 2
2000 2
2001 4
2003 2
2004 2
2006 3
2007 3
2008 3
2009 3
2010 1
2011 6
2012 6
2013 1
2014 1
2015 2
2016 1
2017 1
2018 3
2019 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Gain of Chromosome 7p"
Page 1
Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.
Pezzolo A, Rossi E, Gimelli S, Parodi F, Negri F, Conte M, Pistorio A, Sementa A, Pistoia V, Zuffardi O, Gambini C. Pezzolo A, et al. Neuro Oncol. 2009 Apr;11(2):192-200. doi: 10.1215/15228517-2008-086. Epub 2008 Oct 15. Neuro Oncol. 2009. PMID: 18923191 Free PMC article.
High-resolution array-comparative genomic hybridization (CGH) DNA copy-number analysis technology was used to identify novel prognostic markers. Chromosome 1p36.22p36.32 loss and 1q22qter gain, detected almost exclusively in group 1 patients, were significantly asso …
High-resolution array-comparative genomic hybridization (CGH) DNA copy-number analysis technology was used to identify novel prognostic mark …
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T, Motomura K, Ohka F, Shiina S, Yamamoto T, Nagata Y, Yoshizato T, Mizoguchi M, Abe T, Momii Y, Muragaki Y, Watanabe R, Ito I, Sanada M, Yajima H, Morita N, Takeuchi I, Miyano S, Wakabayashi T, Ogawa S, Natsume A. Aoki K, et al. Neuro Oncol. 2018 Jan 10;20(1):66-77. doi: 10.1093/neuonc/nox132. Neuro Oncol. 2018. PMID: 29016839 Free PMC article.
BACKGROUND: Diffuse lower-grade gliomas (LGGs) are genetically classified into 3 distinct subtypes based on isocitrate dehydrogenase (IDH) mutation status and codeletion of chromosome 1p and 19q (1p/19q). However, the subtype-specific effects of additional genetic lesions …
BACKGROUND: Diffuse lower-grade gliomas (LGGs) are genetically classified into 3 distinct subtypes based on isocitrate dehydrogenase (IDH) m …
Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG, Silveira HCS, Júnior JNA, da Silveira RA, Zucca LE, Cárcano FM, Sanches AON, Neder L, Scapulatempo-Neto C, Serrano SV, Jonasch E, Reis RM, Evangelista AF. Fernandes FG, et al. Int J Mol Sci. 2021 Feb 25;22(5):2265. doi: 10.3390/ijms22052265. Int J Mol Sci. 2021. PMID: 33668731 Free PMC article.
Despite many studies of CNAs in RCC, there are currently no descriptions of genomic copy number alterations in a Brazilian ccRCC cohort. This study was designed to evaluate the chromosomal profile of CNAs in Brazilian ccRCC tumors and explore clinical associations. ...Our …
Despite many studies of CNAs in RCC, there are currently no descriptions of genomic copy number alterations in a Brazilian ccRCC cohort. Thi …
Comparison of Clinical, Histopathological, and Genomic Features Between Malignant Peripheral Nerve Sheath Tumors and Cellular Schwannomas of the Eighth Cranial Nerve: A Case Series.
Zhao F, Zhang S, Du J, Chen Y, Wang B, Zhang J, He Q, Lin L, Zhang L, Yu Y, Liu P. Zhao F, et al. World Neurosurg. 2019 Feb;122:e487-e497. doi: 10.1016/j.wneu.2018.10.087. Epub 2018 Oct 23. World Neurosurg. 2019. PMID: 30366145
The common alterations in MPNSTs mainly included gains of chromosomes 7p, 8p, 9q, 12, and 17 and loss of heterozygosity of 1p, 6 and 9p. The common alterations in CSs included gain of 4p16.3, loss of heterozygosity of 2p15-14, and 22q11.1-13.3. ...
The common alterations in MPNSTs mainly included gains of chromosomes 7p, 8p, 9q, 12, and 17 and loss of heterozygosity of 1p, …
A pilot prospective study of plasma cell-free DNA whole-genome sequencing identified chromosome 7p copy number gains as a specific biomarker for early lung cancer detection.
Yu HJ, Yu XJ, Tang J, Lu X, Ma HT. Yu HJ, et al. Neoplasma. 2021 May;68(3):567-571. doi: 10.4149/neo_2021_201106N1189. Epub 2021 Feb 24. Neoplasma. 2021. PMID: 33618519
Here we investigate whether chromosome 7p copy number gain is a detectable genetic event with plasma cell-free DNA for early lung cancer detection. ...Further analyses showed that chr7p copy number gains tend to be enriched in normal EGFR/KRAS patients (Fishe …
Here we investigate whether chromosome 7p copy number gain is a detectable genetic event with plasma cell-free DNA for …
Chromosomal abnormalities subdivide neuroepithelial tumors into clinically relevant groups.
Hirose Y, Yoshida K. Hirose Y, et al. Keio J Med. 2006 Jun;55(2):52-8. doi: 10.2302/kjm.55.52. Keio J Med. 2006. PMID: 16823260 Free article. Review.
Previous studies using comparative genomic hybridization (CGH) demonstrated that copy number aberrations(CNAs) were frequently recognized in these tumors, and revealed that a gain on chromosomal arm 7q was the most common CNA in diffuse astrocytomas, whereas a small …
Previous studies using comparative genomic hybridization (CGH) demonstrated that copy number aberrations(CNAs) were frequently recognized in …
Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H. Stokke T, et al. Br J Cancer. 2001 Dec 14;85(12):1900-13. doi: 10.1054/bjoc.2001.2164. Br J Cancer. 2001. PMID: 11747333 Free PMC article.

Gains were found at 3q21-ter (22%), 6p (11%), 7p (12%), 8q23-ter (13%), 12cen-q15 (17%), 17q24-ter (13%), and 18q13.3-21 (20%). ...Loss of 8p and 17p, and gain of 3q21-ter, 6p, 7p, and 8q23-ter were associated with a high S phase fraction (P < or = 0.03),

Gains were found at 3q21-ter (22%), 6p (11%), 7p (12%), 8q23-ter (13%), 12cen-q15 (17%), 17q24-ter (13%), and 18q13.3-21 (20%). ...Lo …
Oncogenetic tree modeling of human hepatocarcinogenesis.
Longerich T, Mueller MM, Breuhahn K, Schirmacher P, Benner A, Heiss C. Longerich T, et al. Int J Cancer. 2012 Feb 1;130(3):575-83. doi: 10.1002/ijc.26063. Epub 2011 May 9. Int J Cancer. 2012. PMID: 21400513 Free article.
Nine losses (1p, 4q, 6q, 8p, 9p, 13q, 16p, 16q and 17p) and ten gains (1q, 5p, 6p, 7p, 7q, 8q, 17q, 20p, 20q and Xq) of genomic information were used to build the oncogenetic tree model. ...Using five aberrations that were significantly associated with tumor dedifferentiat …
Nine losses (1p, 4q, 6q, 8p, 9p, 13q, 16p, 16q and 17p) and ten gains (1q, 5p, 6p, 7p, 7q, 8q, 17q, 20p, 20q and Xq) of genomic infor …
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
Tabouret E, Nguyen AT, Dehais C, Carpentier C, Ducray F, Idbaih A, Mokhtari K, Jouvet A, Uro-Coste E, Colin C, Chinot O, Loiseau H, Moyal E, Maurage CA, Polivka M, Lechapt-Zalcman E, Desenclos C, Meyronet D, Delattre JY, Figarella-Branger D; For POLA Network. Tabouret E, et al. Acta Neuropathol. 2016 Oct;132(4):625-34. doi: 10.1007/s00401-016-1611-8. Epub 2016 Aug 29. Acta Neuropathol. 2016. PMID: 27573687
We did not find prognosis differences between grades III and IV for IDH (mut) 1p/19q intact and IDH (wt) gliomas in univariate and multivariate analyses. Among anaplastic astrocytoma IDH (wt), cases with chromosome arm 7p gain and 10q loss (55 %) had shorter …
We did not find prognosis differences between grades III and IV for IDH (mut) 1p/19q intact and IDH (wt) gliomas in univariate and multivari …
Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome.
Ambatipudi S, Gerstung M, Gowda R, Pai P, Borges AM, Schäffer AA, Beerenwinkel N, Mahimkar MB. Ambatipudi S, et al. PLoS One. 2011 Feb 28;6(2):e17250. doi: 10.1371/journal.pone.0017250. PLoS One. 2011. PMID: 21386901 Free PMC article.
The specific genomic alterations so identified were evaluated for their potential clinical relevance. Copy-number changes were observed on chromosomal arms with most frequent gains on 3q (60%), 5p (50%), 7p (50%), 8q (73%), 11q13 (47%), 14q11.2 (47%), and 19p13.3 (5 …
The specific genomic alterations so identified were evaluated for their potential clinical relevance. Copy-number changes were observed on …
43 results